Oncology and Hematology

481-495 of 837

• 

  RestartResume

  How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021

  Project Oncology®

  How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021

• 

  RestartResume

  Equality in Care for All Women: Addressing Disparities in Gynecologic Malignancies at ASCO 2021

  Project Oncology®

  Equality in Care for All Women: Addressing Disparities in Gynecologic Malignancies at ASCO 2021

• 

  RestartResume

  Recapping the ASCO 2021 Annual Meeting Opening Session & Presidential Address

  Project Oncology®

  Recapping the ASCO 2021 Annual Meeting Opening Session & Presidential Address

• 

  RestartResume

  COVID-19 Vaccines & Abnormal Mammograms: A Proposed Plan of Care

  COVID-19: On The Frontlines

  COVID-19 Vaccines & Abnormal Mammograms: A Proposed Plan of Care

  • 

    

    Hector O. Chapa, MD, FACOG

    Peer

• 

  RestartResume

  Advances in Proton Therapy for Pediatric Brain Tumors

  Advanced Treatments & Innovations from Mayo Clinic

  Advances in Proton Therapy for Pediatric Brain Tumors

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Nadia N. Laack, MD

    Peer

• 

  RestartResume

  Investigating Immunotherapy & Its Role in NSCLC

  Project Oncology®

  Investigating Immunotherapy & Its Role in NSCLC

  • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Mark Awad, MD, PhD

    Peer
• advertisement

• 

  RestartResume

  Evaluating Biomarkers at Work in NSCLC

  Project Oncology®

  Evaluating Biomarkers at Work in NSCLC

  • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Mark Awad, MD, PhD

    Peer

• 

  RestartResume

  Lessons in Dermatology Care: Trust Patients’ Intuitions & Ease Fears 

  DermConsult

  Lessons in Dermatology Care: Trust Patients’ Intuitions & Ease Fears 

  • 

    

    Michael Greenberg, MD

    Peer

• 

  RestartResume

  Evaluating HER2 Testing Accuracy: A Brief Overview of the Updated ASCO & CAP Joint Guidelines

  Project Oncology®

  Evaluating HER2 Testing Accuracy: A Brief Overview of the Updated ASCO & CAP Joint Guidelines

  • 

    

    Oudai Hassan, MD

    Peer

• 

  RestartResume

  Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC

  Project Oncology®

  Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC

  • 

    

    D. Ross Camidge, MD, PhD

    Peer

• 

  RestartResume

  ASCO Investigates Disparities in Cancer Care: Representation in Oncology

  Project Oncology®

  ASCO Investigates Disparities in Cancer Care: Representation in Oncology

  • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Lori Pierce, MD, FASTRO, FASCO

    Peer

• 

  RestartResume

  Discovering Disparities in Diversity: Representation in Clinical Trials

  Clinician's Roundtable

  Discovering Disparities in Diversity: Representation in Clinical Trials

  • 

    

    Jennifer Caudle, DO, FACOFP

    Peer

  • 

    

    Narjust Duma, MD

    Peer
• advertisement

• 

  RestartResume

  Perspectives on Pancreatic Cysts: How to Determine Malignancy

  GI Insights

  Perspectives on Pancreatic Cysts: How to Determine Malignancy

  • 

    

    Peter Buch, MD, FACG, AGAF, FACP

    Peer

  • 

    

    Rajeev Attam, MD

    Peer

• 

  RestartResume

  Understanding Updates in Lung Cancer Screening

  Spotlight on Lung Cancer

  Understanding Updates in Lung Cancer Screening

  • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Andrea B. McKee, MD

    Peer

• 

  RestartResume

  Assessing Quality of Care: Implementing a Lung Screening Program

  Spotlight on Lung Cancer

  Assessing Quality of Care: Implementing a Lung Screening Program

  • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Andrea B. McKee, MD

    Peer

• Prev
• 1
• 2
• …
• 31
• 32
• 33
• 34
• 35
• …
• 55
• 56
• Next